Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Pediatricians should advise sexually active teens on safe sex and STD prevention, and discuss contraceptive options and their side effects.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Some birth control pills have a higher risk of blood clots than others.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Hormone therapy for trans individuals is effective and generally safe in the short term.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

PCOS requires personalized treatment to manage symptoms and improve fertility and quality of life.